Sign in
Not yet recruitingNo phase

The Efficacy of a Polarized Folded Optical Path-based Reading-writing Desk for Myopia Prevention and Control in Pre-myopic Children

Key facts

Who runs it
Beijing Tongren Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
200 people, planned
Started
13 Oct 2026
Expected to end
30 Jun 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Polarized folded optical path reading and writing device
  • Eye-care desk lamp and desk posture corrector
Record updated
3 November 2026

Who can take part

Age
5 years to 10 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age 5 to 10 years (inclusive) on the date of signing informed consent
  • Pre myopia status, defined as a spherical equivalent refraction (SER) measured by cycloplegic refraction in both eyes, with values satisfying -0.50 D < SER ≤ +0.75 D
  • Astigmatism (cylinder power) ≤1.50 D and anisometropia ≤1.50 D in both eyes
  • A daily need for reading and writing, and a home environment that allows the use of the reading and writing device / eye protection desk lamp and posture corrector
  • Signed informed consent obtained from the parent(s) or legal guardian(s); for children aged 7 years and older, an additional child assent form must also be signed
  • Willingness to comply with the scheduled follow up visits throughout the 24 month study period, with no plan for long term relocation to a different area

Who cannot take part

  • Use of any of the following myopia control interventions within 6 months prior to enrollment: orthokeratology (OK) lenses, low concentration atropine, repeated low level red light therapy, defocus incorporated soft contact lenses, peripheral defocus spectacle lenses, pirenzepine, or any other medication/device known to have a myopia control effect
  • Any ocular disease that may affect refractive development, including amblyopia, strabismus, congenital cataract, glaucoma, keratoconus, ptosis, significant ocular surface disease, or other relevant conditions
  • Presence of systemic diseases (e.g., neurodevelopmental disorders, connective tissue diseases, or ongoing systemic glucocorticoid therapy or other medications affecting ocular development) that may influence visual development or study compliance
  • Known allergy to cycloplegic agents in the child or parent/guardian
  • Any other condition deemed by the principal investigator (PI) to render the participant unsuitable for enrollment
  • Explicit statement by the parent/guardian of intention to use additional myopia interventions during the study period

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 5 and 10 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate the efficacy and safety of the polarized folded optical path reading and writing device in myopia prevention onset in 5-10 year old children with pre myopia. It will also integrate AI based fundus photography risk stratification, wearable environmental exposure monitoring, and far display screen behavioral recognition data to construct predictive models for myopia onset risk and intervention response, thereby establishing a precision prevention and control paradigm for this population. The main questions it aims to answer are:

Read full original descriptionShow less

* How can early risk identification, scenario based precision intervention, and objective efficacy prediction be achieved in pre myopic children? * What is the mechanism of action of the device on the accommodation-choroid-axial length axis? * What is the dose-response relationship among multispectral input, real world visual behaviors, and prophylactic efficacy? * How does the multimodal collaborative regulatory mechanism integrating risk stratification, environmental monitoring, and behavioral recognition operate? Researchers will compare participants using the polarized folded optical path reading and writing device against those not equipped with equivalent viewing distance extending optical devices (Intervention Group: using the polarized folded optical path reading and writing device; control group: not equipped with equivalent viewing distance extending optical devices) to determine the relative efficacy of the device in controlling myopia progression.

Participants will:

* If assigned to the intervention group, use the polarized folded optical path reading and writing device as their daily reading and writing tool for 12 months, with a target usage of ≥2 hours/day and ≥5 compliant days/week; if assigned to the control group, use myopia prevention desk lamps and posture correctors while maintaining their habitual visual behaviors. * Attend clinic visits at baseline and at 3, 6, 9, and 12 months for comprehensive eye examinations. * Maintain diaries documenting wearable environmental exposure data, real world far display screen usage behaviors, and any adverse events; additionally, undergo collection of color fundus photographs and AI derived fundus risk scores at the scheduled visits.

The 2 groups in the trial

  • polarized folded optical path reading and writing deviceTreatment being tested
  • Control groupExisting treatment, for comparison

    Treatment: Eye-care desk lamp and desk posture corrector

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Controlled Trial on the Efficacy of a Polarized Folded Optical Path-based Reading-writing Desk for Myopia Prevention and Control in Pre-myopic Children
Fit questions
Built from NCT07914114, who can take part
Record updated
3 November 2026